These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


375 related items for PubMed ID: 2184527

  • 1. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL, Brink BA.
    S Afr Med J; 1990 Apr 21; 77(8):390-1. PubMed ID: 2184527
    [Abstract] [Full Text] [Related]

  • 2. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr 11; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Failure of a prothionamide-containing oral antituberculosis regimen.
    Langton ME, Cowie RL.
    S Afr Med J; 1985 Dec 07; 68(12):881. PubMed ID: 4071346
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA.
    S Afr Med J; 1996 Feb 07; 86(2):155-8. PubMed ID: 8619142
    [Abstract] [Full Text] [Related]

  • 10. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H.
    Kekkaku; 1994 Nov 07; 69(11):671-80. PubMed ID: 7837720
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ, Perng RP.
    Int J Tuberc Lung Dis; 2002 Nov 07; 6(11):1029-32. PubMed ID: 12475151
    [Abstract] [Full Text] [Related]

  • 17. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov 09; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 09; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.